Gracell Biotechnologies I... (GRCL)
Gracell Biotechnologies Max Pain By Strike
GRCL trades at $10.25, 89.2% below the near-term max pain of $95 expiring Jan 16, 2026 (153 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is stable across expirations ($95-$95), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.
Gracell Biotechnologies Max Pain By Expiry
Max pain for GRCL shows stable levels around 95.00, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels above 10.25 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Jan 16, 2026 | 95 | 84.75 (826.83%) |